February 2024
1. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
   The INSPIRE study: RSV infection during infancy - Authors' reply.
   Lancet. 2024;403:729-730.
   

   >> Share

   
   January 2024
2. QUINT JK, Shah PL
   What trials do and do not tell us about treatments for severe asthma.
   Lancet. 2024;403:224-226.
   

   >> Share

   
   December 2023
3. DRUCKER NA, Cox CS Jr
   Adult presentation of congenital tracheooesophageal fistula treated as asthma and recurrent respiratory infections.
   Lancet. 2023;402:2326-2327.
   

   >> Share

   
   
4. JACKSON DJ, Heaney LG, Humbert M, Kent BD, et al
   Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
   Lancet. 2023 Dec 7:S0140-6736(23)02284-5. doi: 10.1016/S0140-6736(23)02284.
   

   >> Share

   
   November 2023
5. ALYAMI RA, Simpson R, Oliver P, Julious SA, et al
   Evaluation of the impact of letters to GP practices to promote asthma prescription uptake in school-age children during summer (TRAINS study): a pragmatic cluster-randomised controlled trial.
   Lancet. 2023;402 Suppl 1:S22.
   

   >> Share

   
   
6. GEDEON E, Henderson M, Leyland AH, Allik M, et al
   Association between care experience and mental health hospitalisation among children in Scotland, with a focus on chronic conditions (CHiCS): a population-wide longitudinal study using administrative data.
   Lancet. 2023;402 Suppl 1:S5.
   

   >> Share

   
   July 2023
7. LEVY ML, Bateman ED, Allan K, Bacharier LB, et al
   Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective.
   Lancet. 2023 Jul 19:S0140-6736(23)01358-2. doi: 10.1016/S0140-6736(23)01358.
   

   >> Share

   
   April 2023
8. BILLARD MN, Bont LJ
   The link between respiratory syncytial virus infection during infancy and asthma during childhood.
   Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672.
   

   >> Share

   
   
9. ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al
   Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.
   Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811.
   

   >> Share

   
   January 2023
10. PORSBJERG C, Melen E, Lehtimaki L, Shaw D, et al
    Asthma.
    Lancet. 2023 Jan 19:S0140-6736(22)02125-0. doi: 10.1016/S0140-6736(22)02125.
    

    >> Share

    
    August 2022
11. JACKSON DJ, Bacharier LB, Gergen PJ, Gagalis L, et al
    Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial.
    Lancet. 2022;400:502-511.
    

    >> Share

    
    
12. KELLY RS, Weiss ST
    Biologic therapies for asthma in underserved populations.
    Lancet. 2022;400:471-473.
    

    >> Share

    
    April 2022
13. LOMMATZSCH M, Brusselle GG, Canonica GW, Jackson DJ, et al
    Disease-modifying anti-asthmatic drugs.
    Lancet. 2022;399:1664-1668.
    

    >> Share

    
    October 2021
14. ASHER MI, Rutter CE, Bissell K, Chiang CY, et al
    Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study.
    Lancet. 2021;398:1569-1580.
    

    >> Share

    
    
15. PIJNENBURG MW, Nantanda R
    Rising and falling prevalence of asthma symptoms.
    Lancet. 2021;398:1542-1543.
    

    >> Share

    
    
16. JANKAUSKAITE L, Oostenbrink R
    Childhood lower respiratory tract infections: more evidence to do less.
    Lancet. 2021;398:1383-1384.
    

    >> Share

    
    
17. BUSH A, Pavord ID
    Forthcoming UK asthma guidelines: an opportunity to improve asthma outcomes.
    Lancet. 2021 Oct 14. pii: S0140-6736(21)02244.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share